Intellia Therapeutics Inc
NTLAHealthcare|Biotechnology|USA
$14.21
-1.23 (-7.99%)
Tangible Book
$5.16
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (121)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dulac Edward J III | EVP, CFO | 2026-07-02 | SELL | 4,677 | $18 | $84.2K |
| Dube Michael P | VP, Chief Accounting Officer | 2026-07-01 | SELL | 2,641 | $16.78 | $44.3K |
| BASTA JAMES | EVP, General Counsel | 2026-03-02 | SELL | 1,211 | $13.78 | $16.7K |
| Clark Eliana | EVP, Chief Technical Officer | 2026-03-02 | SELL | 607 | $13.78 | $8.4K |
| Schultes Birgit C | EVP, Chief Scientific Officer | 2026-01-05 | SELL | 8,508 | $9.21 | $78.4K |
| Cohen Fred E | Director | 2026-01-05 | BUY | 150,000 | $9.35 | $1402.5K |
| Lebwohl David | EVP, Chief Medical Officer | 2026-01-05 | SELL | 11,903 | $9.21 | $109.6K |
| Clark Eliana | EVP, Chief Technical Officer | 2026-01-05 | SELL | 9,515 | $9.21 | $87.6K |
| Dulac Edward J III | EVP, CFO | 2026-01-05 | SELL | 6,379 | $9.21 | $58.8K |
| Dube Michael P | VP, Chief Accounting Officer | 2026-01-05 | SELL | 2,989 | $9.21 | $27.5K |
| LEONARD JOHN M | President and CEO | 2026-01-05 | SELL | 34,146 | $9.21 | $314.5K |
| LEONARD JOHN M | President and CEO | 2025-12-11 | SELL | 88,146 | $9.49 | $836.5K |
| Schultes Birgit C | EVP, Chief Scientific Officer | 2025-10-01 | SELL | 31 | $17.38 | $0.5K |
| Dube Michael P | VP, Chief Accounting Officer | 2025-10-01 | SELL | 1,871 | $17.38 | $32.5K |
| CHASE WILLIAM J | Director | 2025-08-20 | BUY | 100,000 | $10.03 | $1003K |
| Dulac Edward J III | EVP, CFO | 2025-07-23 | SELL | 7,462 | $14.02 | $104.6K |
| Dube Michael P | VP, Chief Accounting Officer | 2025-07-02 | SELL | 2,503 | $9.95 | $24.9K |
| GOODMAN JESSE | Director | 2025-07-01 | SELL | 3,094 | $9.4 | $29.1K |
| Clark Eliana | EVP, Chief Technical Officer | 2025-07-01 | SELL | 1,022 | $9.82 | $10K |
| Bhanji Muna | Director | 2025-04-29 | SELL | 265 | $8.5 | $2.3K |
| Bhanji Muna | Director | 2025-01-29 | SELL | 265 | $9.97 | $2.6K |
| LEONARD JOHN M | President and CEO | 2025-01-03 | SELL | 26,807 | $12.18 | $326.5K |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2025-01-03 | SELL | 8,966 | $12.18 | $109.2K |
| Dube Michael P | VP, Chief Accounting Officer | 2025-01-03 | SELL | 1,372 | $12.18 | $16.7K |
| BASTA JAMES | EVP, General Counsel | 2025-01-03 | SELL | 7,074 | $12.18 | $86.2K |
| Clark Eliana | EVP, Chief Technical Officer | 2025-01-03 | SELL | 7,978 | $12.17 | $97.1K |
| Lebwohl David | EVP, Chief Medical Officer | 2025-01-03 | SELL | 9,557 | $12.18 | $116.4K |
| Hicks Derek | EVP, Chief Business Officer | 2025-01-03 | SELL | 6,502 | $12.18 | $79.2K |
| Dube Michael P | VP, Chief Accounting Officer | 2024-10-02 | SELL | 2,012 | $19.01 | $38.2K |
| Clark Eliana | EVP, Chief Technical Officer | 2024-07-01 | SELL | 405 | $22.93 | $9.3K |
| Verwiel Frank | Director | 2024-06-17 | SELL | 1,505 | $25 | $37.6K |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2024-01-08 | SELL | 2,275 | $28.87 | $65.7K |
| LEONARD JOHN M | President and CEO | 2024-01-03 | SELL | 19,223 | $29.46 | $566.3K |
| Lebwohl David | EVP, Chief Medical Officer | 2024-01-03 | SELL | 5,843 | $29.46 | $172.1K |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2024-01-03 | SELL | 5,532 | $29.46 | $163K |
| Goddard Glenn | EVP, CFO | 2024-01-03 | SELL | 5,365 | $29.46 | $158.1K |
| Hicks Derek | EVP, Chief Business Officer | 2024-01-03 | SELL | 3,877 | $29.46 | $114.2K |
| BASTA JAMES | EVP, General Counsel | 2024-01-03 | SELL | 3,805 | $29.46 | $112.1K |
| Clark Eliana | EVP, Chief Technical Officer | 2024-01-03 | SELL | 4,608 | $29.5 | $135.9K |
| Bhanji Muna | Director | 2023-10-31 | SELL | 265 | $23.9 | $6.3K |
| Bhanji Muna | Director | 2023-07-31 | SELL | 265 | $42.33 | $11.2K |
| Bhanji Muna | Director | 2023-07-06 | SELL | 1,867 | $39.3 | $73.4K |
| Clark Eliana | EVP, Chief Technical Officer | 2023-07-03 | SELL | 360 | $40.51 | $14.6K |
| Clark Eliana | EVP, Chief Technical Officer | 2023-06-20 | SELL | 5,000 | $45 | $225K |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2023-01-05 | SELL | 4,838 | $37.82 | $183K |
| LEONARD JOHN M | President and CEO | 2023-01-04 | SELL | 6,673 | $37.21 | $248.3K |
| Hicks Derek | EVP, Chief Business Officer | 2023-01-04 | SELL | 1,812 | $37.21 | $67.4K |
| Lebwohl David | EVP, Chief Medical Officer | 2023-01-04 | SELL | 2,574 | $37.21 | $95.8K |
| Goddard Glenn | EVP, CFO | 2023-01-04 | SELL | 2,427 | $37.21 | $90.3K |
| Clark Eliana | EVP, Chief Technical Officer | 2023-01-04 | SELL | 2,028 | $37.65 | $76.4K |
| BASTA JAMES | EVP, General Counsel | 2023-01-04 | SELL | 1,138 | $37.21 | $42.3K |
| LEONARD JOHN M | President and CEO | 2022-01-01 | SELL | 2,493 | $112.26 | $279.9K |
| Goddard Glenn | EVP, CFO | 2022-01-01 | SELL | 1,013 | $112.24 | $113.7K |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2022-01-01 | SELL | 1,148 | $112.25 | $128.9K |
| Lebwohl David | EVP, Chief Medical Officer | 2022-01-01 | SELL | 1,051 | $112.24 | $118K |
| Lebwohl David | EVP, Chief Medical Officer | 2021-11-05 | SELL | 2,400 | $132.72 | $318.5K |
| Lebwohl David | EVP, Chief Medical Officer | 2021-10-14 | SELL | 2,400 | $128.44 | $308.3K |
| Crowley John F | Director | 2021-10-11 | SELL | 2,500 | $119.55 | $298.9K |
| Crowley John F | Director | 2021-10-05 | SELL | 10,000 | $130.54 | $1305.4K |
| Lebwohl David | EVP, Chief Medical Officer | 2021-09-21 | SELL | 2,400 | $149.81 | $359.5K |
| Goddard Glenn | EVP, CFO | 2021-09-07 | SELL | 3,482 | $180.12 | $627.2K |
| LEONARD JOHN M | President and CEO | 2021-09-01 | SELL | 121,372 | $160.83 | $19520.3K |
| Goddard Glenn | EVP, CFO | 2021-08-31 | SELL | 30,000 | $159.45 | $4783.5K |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2021-08-30 | SELL | 97,000 | $154.83 | $15018.5K |
| Lebwohl David | EVP, Chief Medical Officer | 2021-08-30 | SELL | 2,400 | $158.04 | $379.3K |
| LEONARD JOHN M | President and CEO | 2021-08-23 | SELL | 27,139 | $152.01 | $4125.4K |
| LEONARD JOHN M | President and CEO | 2021-08-19 | SELL | 22,682 | $151.28 | $3431.3K |
| Lebwohl David | EVP, Chief Medical Officer | 2021-08-09 | SELL | 2,400 | $164.05 | $393.7K |
| Goddard Glenn | EVP, CFO | 2021-08-05 | SELL | 20,000 | $151.05 | $3021K |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2021-08-04 | SELL | 26,000 | $138.24 | $3594.2K |
| FORMELA JEAN FRANCOIS | Director | 2021-06-14 | SELL | 201,725 | $87.04 | $17558.1K |
| FORMELA JEAN FRANCOIS | Director | 2021-04-29 | SELL | 4,513 | $85.43 | $385.5K |
| FORMELA JEAN FRANCOIS | Director | 2021-04-28 | SELL | 342,962 | $85.96 | $29481K |
| DORSA CAROLINE | Director | 2021-04-05 | SELL | 7,500 | $82.19 | $616.4K |
| LEONARD JOHN M | President and CEO | 2021-04-01 | SELL | 38,209 | $83.64 | $3195.8K |
| Rivera Jose E | EVP, General Counsel | 2021-04-01 | SELL | 50,455 | $82.46 | $4160.5K |
| FORMELA JEAN FRANCOIS | Director | 2021-02-26 | SELL | 501,945 | $60.29 | $30262.3K |
| Rivera Jose E | EVP, General Counsel | 2021-02-09 | SELL | 11,489 | $75 | $861.7K |
| LEONARD JOHN M | President and CEO | 2021-02-09 | SELL | 50,985 | $71.7 | $3655.6K |
| LEONARD JOHN M | President and CEO | 2021-02-03 | SELL | 177,745 | $67.26 | $11955.1K |
| Rivera Jose E | EVP, General Counsel | 2021-02-01 | SELL | 54,659 | $63.99 | $3497.6K |
| SCHIERMEIER ANDREW | EVP, COO | 2021-01-05 | SELL | 1,377 | $55.86 | $76.9K |
| Rivera Jose E | EVP, General Counsel | 2021-01-05 | SELL | 2,078 | $55.86 | $116.1K |
| LEONARD JOHN M | President and CEO | 2021-01-05 | SELL | 6,239 | $55.86 | $348.5K |
| KARSEN PERRY A | Director | 2020-12-17 | SELL | 88,764 | $53.55 | $4753.3K |
| Rivera Jose E | EVP, General Counsel | 2020-12-01 | SELL | 3,364 | $38.21 | $128.5K |
| LEONARD JOHN M | President and CEO | 2020-11-27 | SELL | 35,000 | $38.57 | $1350K |
| LEONARD JOHN M | President and CEO | 2020-11-25 | SELL | 50,000 | $36 | $1800K |
| Rivera Jose E | EVP, General Counsel | 2020-11-18 | SELL | 6,653 | $34.36 | $228.6K |
| LEONARD JOHN M | President and CEO | 2020-11-16 | SELL | 20,000 | $34 | $680K |
| Rivera Jose E | EVP, General Counsel | 2020-11-04 | SELL | 3,364 | $28 | $94.2K |
| LEONARD JOHN M | President and CEO | 2020-11-04 | SELL | 50,000 | $26 | $1300K |
| Rivera Jose E | EVP, General Counsel | 2020-10-15 | SELL | 5,615 | $24.2 | $135.9K |
| LEONARD JOHN M | President and CEO | 2020-10-07 | SELL | 5,000 | $21.83 | $109.2K |
| Rivera Jose E | EVP, General Counsel | 2020-09-15 | SELL | 5,615 | $21.04 | $118.1K |
| LEONARD JOHN M. | President and CEO | 2020-09-01 | SELL | 5,000 | $21.83 | $109.2K |
| Rivera Jose E | EVP, General Counsel | 2020-08-18 | SELL | 5,615 | $21 | $117.9K |
| LEONARD JOHN M. | President and CEO | 2020-08-06 | SELL | 5,000 | $21.83 | $109.2K |
| Rivera Jose E | EVP, General Counsel | 2020-07-15 | SELL | 5,615 | $22.7 | $127.5K |
| LEONARD JOHN M. | President and CEO | 2020-07-01 | SELL | 5,000 | $21.83 | $109.2K |
| Rivera Jose E | EVP, General Counsel | 2020-06-16 | SELL | 5,615 | $21 | $117.9K |
| LEONARD JOHN M. | President and CEO | 2020-06-03 | SELL | 5,000 | $21.83 | $109.2K |
| Rivera Jose E | EVP, General Counsel | 2020-05-26 | SELL | 5,615 | $21.21 | $119.1K |
| SCHIERMEIER ANDREW | EVP, Dev and Corp Strategy | 2019-03-06 | BUY | 7,500 | $15.72 | $117.9K |
| FORMELA JEAN FRANCOIS | Director | 2018-07-16 | SELL | 6,686 | $31.17 | $208.4K |
| FORMELA JEAN FRANCOIS | Director | 2018-06-19 | SELL | 6,686 | $27.96 | $186.9K |
| FORMELA JEAN FRANCOIS | Director | 2018-05-16 | SELL | 6,686 | $25.04 | $167.4K |
| LEONARD JOHN M. | President and CEO | 2018-05-14 | SELL | 8,400 | $24 | $201.6K |
| FORMELA JEAN FRANCOIS | Director | 2018-03-20 | SELL | 39,245 | $23.87 | $936.8K |
| Caribou Biosciences, Inc. | 10% Owner | 2018-01-29 | SELL | 550,645 | $26.78 | $14746.3K |
| Novartis Institutes for BioMed | 10% Owner | 2017-12-12 | SELL | 1,523,000 | $18.3 | $27870.9K |
| Bermingham Nessan | President & CEO | 2017-12-08 | SELL | 336,783 | $20.78 | $6998.4K |
| FORMELA JEAN FRANCOIS | Director | 2017-07-11 | SELL | 150,000 | $16.24 | $2436K |
| Atlas Venture Fund IX, L.P. | 10% Owner | 2017-07-11 | SELL | 150,000 | $16.24 | $2436K |
| Atlas Venture Associates IX, L | 10% Owner | 2017-03-10 | SELL | 21,132 | $13.91 | $293.9K |
| FORMELA JEAN FRANCOIS | Director | 2017-03-10 | SELL | 21,132 | $13.91 | $293.9K |
| BAKER BROS. ADVISORS LP | 2016-05-11 | BUY | 200,000 | $18 | $3600K | |
| ORBIMED ADVISORS LLC | Director | 2016-05-11 | BUY | 250,000 | $18 | $4500K |
| Temasek Holdings (Private) Ltd | 10% Owner | 2016-05-11 | BUY | 300,000 | $18 | $5400K |
| Novartis Institutes for BioMed | 10% Owner | 2016-05-11 | BUY | 277,777 | $18 | $5000K |
| GORDON CARL L | Director | 2016-05-11 | BUY | 250,000 | $18 | $4500K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked